TrialsgrambetaRCTs are beautiful

MIND-USA

2018

Modifying the Impact of ICU-Associated Neurological Dysfunction

In 566 ICU patients with delirium, haloperidol or ziprasidone did not change delirium duration versus placebo.

Result

Primary endpoint: Days alive without delirium or coma

Median days alive without delirium/coma: 8.5 (placebo) vs 7.9 (haloperidol) vs 8.7 (ziprasidone); P=0.26 overall. No difference.

Original publication
Subtopic
Delirium
Design
Multicentre RCT, USA
Relevance
Important: one of several pillars.
Source
Girard TD, et al. N Engl J Med. 2018;379(26):2506-2516.doi 10.1056/NEJMoa1808217

Discussion & critique

Killed routine antipsychotic prophylaxis/treatment for ICU delirium.

Discussed in podcasts